A multireceptorial binding reinvestigation on an extended class of sigma ligands: N-[omega-(Indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards sigma(1) and EBP sites
F. Berardi et al., A multireceptorial binding reinvestigation on an extended class of sigma ligands: N-[omega-(Indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards sigma(1) and EBP sites, BIO MED CH, 9(5), 2001, pp. 1325-1335
New 1-[omega-(2,3-dihydro-1H-inden-1-yl)- and (2,3-dihydro-5-methoxy-1H-ind
en-1-yl)alkyl and 1-[omega-(1,2,3,4-tetrahydronaphthalen-1-yl)- and (6-meth
oxy- or 6-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)aIkyl] derivatives of 3,
3-dimethylpiperidine were synthesized, as homologous compounds of an existi
ng series of sigma ligands, in order to carry out sigma receptor subtypes s
tructure-affinity relationships. The new compounds and some of their relate
d analogues, already reported, were tested in new multi-receptorial radioli
gand binding assays. As reference compounds, the known sigma (1) ligands SA
4503, ED 1008 and NE 100 were also prepared and tested. All reported compo
unds showed high sigma (1) affinity assayed by (+)-[H-3]-pentazocine on gui
nea-pig brain (apparent K-i = 1.75-72.2 nM) and moderate or low sigma (2) a
ffinity by [H-3]-DTG on rat liver, in contrast with previous results. One t
ertiary amine function spaced by a five-membered chain from a phenyl group
is the structural feature shared by the most active compounds 26 and 43 and
some reference al ligands. The reported ol ligands, including reference co
mpounds, also demonstrated a high affinity towards EBP (Delta (8)-Delta (7)
sterol isomerase) site (apparent K-i = 0.48-14.8 nM) and some of them (37
and 44) were good ligands at L-type Ca++ channel. 1-14-(2,3-Dihydro- 1H-ind
en-1-yl)butyl]-3,3-dimethylpiperidine (26) was the best mixed sigma (1) and
EBP ligand (apparent K-i = 1.75 and 1.54 nM, respectively) with a good sel
ectivity versus sigma (2) receptor (138- and 157-fold, respectively). (C) 2
001 Elsevier Science Ltd. All rights reserved.